These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 1374320

  • 1. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL, Clissold SP.
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
    Lücker P, Moore G, Wieselgren I, Olofsson B, Bergstrand R.
    J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic and pharmacodynamic properties of controlled release (CR/ZOK) metoprolol in healthy Oriental subjects: a comparison with conventional formulations of metoprolol and atenolol.
    Darmansjah I, Wong E, Setiawati A, Moeloek D, Irawati D, Siagian M, Muchtar A.
    J Clin Pharmacol; 1990 Feb; 30(S2):S39-45. PubMed ID: 2312778
    [Abstract] [Full Text] [Related]

  • 4. A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation.
    Oosterhuis B, Jonkman J, Zuiderwijk P, Sollie F.
    J Clin Pharmacol; 1990 Feb; 30(S2):S33-8. PubMed ID: 2312777
    [Abstract] [Full Text] [Related]

  • 5. Tolerability and well-being with metoprolol in a controlled release (CR/ZOK) formulation: a review article.
    Dimenäs E, Dahlöf C.
    J Clin Pharmacol; 1990 Feb; 30(S2):S92-7. PubMed ID: 2179287
    [Abstract] [Full Text] [Related]

  • 6. Treatment with beta-blockers--the value of an even plasma concentration over 24 h.
    Agewall S, Kendall M.
    J Clin Pharm Ther; 1997 Jun; 22(3):171-9. PubMed ID: 9447471
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic and pharmacodynamic evaluation of metoprolol controlled release (CR/ZOK) 50 mg in young subjects.
    Wieselgren I, Lundborg P, Sandberg A, Olofsson B, Bergstrand R.
    J Clin Pharmacol; 1990 Feb; 30(S2):S28-32. PubMed ID: 2312776
    [Abstract] [Full Text] [Related]

  • 8. Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications.
    Kendall MJ, Maxwell SR, Sandberg A, Westergren G.
    Clin Pharmacokinet; 1991 Nov; 21(5):319-30. PubMed ID: 1773547
    [Abstract] [Full Text] [Related]

  • 9. A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.
    Klein G, Berger J, Olsson G, Menzel T.
    J Clin Pharmacol; 1990 Feb; 30(S2):S72-7. PubMed ID: 2179284
    [Abstract] [Full Text] [Related]

  • 10. Beta-adrenoceptor blockade and CNS-related subjective symptoms: a randomized, double-blind, placebo-controlled comparison of metoprolol CR/ZOK, atenolol and propranolol LA in healthy subjects.
    Dimenäs E, Kerr D, Macdonald I.
    J Clin Pharmacol; 1990 Feb; 30(S2):S103-7. PubMed ID: 1968912
    [Abstract] [Full Text] [Related]

  • 11. Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.
    Benfield P, Clissold SP, Brogden RN.
    Drugs; 1986 May; 31(5):376-429. PubMed ID: 2940080
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The efficacy of low dose metoprolol CR/ZOK in mild hypertension and in elderly patients with mild to moderate hypertension.
    Jäättelä A, Baandrup S, Houtzagers J, Westergren G.
    J Clin Pharmacol; 1990 Feb; 30(S2):S66-71. PubMed ID: 2179283
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The relationship between metoprolol plasma concentration and beta 1-blockade in healthy subjects: a study on conventional metoprolol and metoprolol CR/ZOK formulations.
    Abrahamsson B, Lücker P, Olofsson B, Regårdh CG, Sandberg A, Wieselgren I, Bergstrand R.
    J Clin Pharmacol; 1990 Feb; 30(S2):S46-54. PubMed ID: 1968913
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic and biopharmaceutic aspects of once daily treatment with metoprolol CR/ZOK: a review article.
    Sandberg A, Abrahamsson B, Regårdh CG, Wieselgren I, Bergstrand R.
    J Clin Pharmacol; 1990 Feb; 30(S2):S2-16. PubMed ID: 2179280
    [Abstract] [Full Text] [Related]

  • 19. A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension.
    Chen MF, Yang CY, Chen WJ, Lee CM, Wu CC, Liau CS, Lee YT.
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):401-6. PubMed ID: 8527349
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.
    Blomqvist I, Westergren G, Sandberg A, Jonsson UE, Lundborg P.
    Eur J Clin Pharmacol; 1988 Jun; 33 Suppl():S19-24. PubMed ID: 3371390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.